Gregg Fromell

2.2k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Gregg Fromell is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Gregg Fromell has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 7 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Gregg Fromell's work include Acute Myocardial Infarction Research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregg Fromell is often cited by papers focused on Acute Myocardial Infarction Research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers) and Atrial Fibrillation Management and Outcomes (6 papers). Gregg Fromell collaborates with scholars based in United States, Canada and Argentina. Gregg Fromell's co-authors include Frédérique Bigonzi, Enrique Gurfinkel, Anatoly Langer, Keith A.A. Fox, Christine Demers, Alexander G.G. Turpie, Robert M. Califf, Jerôme Premmereur, Beth Davison Weatherley and Shaun Goodman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Gregg Fromell

19 papers receiving 1.4k citations

Hit Papers

A Comparison of Low-Molec... 1997 2026 2006 2016 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
    1997 1.0k citations Marc J. Cohen, Christine Demers et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gregg Fromell 1.2k 664 603 322 74 19 1.5k
Ruth Harper 1.9k 1.6× 762 1.1× 353 0.6× 124 0.4× 24 0.3× 16 2.2k
Giulio Francesco Romiti 1.5k 1.2× 274 0.4× 185 0.3× 129 0.4× 53 0.7× 114 2.2k
Jannik Langtved Pallisgaard 957 0.8× 288 0.4× 144 0.2× 78 0.2× 16 0.2× 64 1.2k
Albert Yuh‐Jer Shen 982 0.8× 202 0.3× 354 0.6× 58 0.2× 30 0.4× 21 1.4k
Huon Gray 825 0.7× 149 0.2× 406 0.7× 165 0.5× 22 0.3× 53 1.3k
Michel R. Le May 1.7k 1.4× 213 0.3× 885 1.5× 471 1.5× 30 0.4× 61 2.1k
Savion Gropper 1.0k 0.8× 449 0.7× 205 0.3× 70 0.2× 55 0.7× 29 1.2k
M. L. Simoons 1.6k 1.3× 197 0.3× 823 1.4× 509 1.6× 27 0.4× 45 2.0k
José Marı́a Garcı́a-Acuña 1.4k 1.2× 77 0.1× 383 0.6× 335 1.0× 36 0.5× 129 1.9k
Liang-Miin Tsai 582 0.5× 85 0.1× 176 0.3× 175 0.5× 25 0.3× 53 958

Countries citing papers authored by Gregg Fromell

Since Specialization
Citations

This map shows the geographic impact of Gregg Fromell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg Fromell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg Fromell more than expected).

Fields of papers citing papers by Gregg Fromell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg Fromell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg Fromell. The network helps show where Gregg Fromell may publish in the future.

Co-authorship network of co-authors of Gregg Fromell

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg Fromell. A scholar is included among the top collaborators of Gregg Fromell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg Fromell. Gregg Fromell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schlauch, Daniel, Ashraf Reyad, Mick Correll, et al.. (2021). Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in the United States. Clinical Transplantation. 35(4). e14216–e14216. 36 indexed citations
2.
Junglen, Angela G., Casey Martin, Pratik Doshi, et al.. (2021). Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19. Journal of Clinical Investigation. 131(20). 24 indexed citations
3.
4.
5.
Burnett, Bruce K., Gregg Fromell, Karen Hartman, et al.. (2010). Support for Investigator-Initiated Clinical Research Involving Investigational Drugs or Devices: The Clinical and Translational Science Award Experience. Academic Medicine. 86(2). 217–223. 18 indexed citations
6.
Fromell, Gregg. (2008). Good Clinical Practice Standards: What They Are and Some Tools to Support Them. Human Gene Therapy. 19(5). 431–440. 3 indexed citations
7.
Berkowitz, Scott D., Sandra S. Stinnett, Marc Cohen, Gregg Fromell, & Frédérique Bigonzi. (2001). Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 88(11). 1230–1234. 25 indexed citations
8.
Goodman, Shaun G., Aiala Barr, Marc Cohen, et al.. (2000). Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. Journal of the American College of Cardiology. 36(5). 1507–1513. 42 indexed citations
9.
10.
Stinnett, Sandra S., Beth Davison Weatherley, Enrique Gurfinkel, et al.. (2000). Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy. American Heart Journal. 139(6). 962–970. 25 indexed citations
11.
Cohen, Marc, Christine Demers, Enrique Gurfinkel, et al.. (1998). Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial. The American Journal of Cardiology. 82(5). 19L–24L. 68 indexed citations
12.
Cohen, Mauricio G., et al.. (1998). One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non-Q-wave myocardial infarction). Journal of the American College of Cardiology. 31. 79–79. 7 indexed citations
13.
Cohen, Marc J., Christine Demers, Enrique Gurfinkel, et al.. (1997). A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease. New England Journal of Medicine. 337(7). 447–452. 1004 indexed citations breakdown →
14.
15.
Cutler, Neal R., et al.. (1995). Dose‐Ranging Study of a New, Once‐Daily Diltiazem Formulation for Patients with Stable Angina. The Journal of Clinical Pharmacology. 35(2). 189–195. 5 indexed citations
16.
Pool, Peter E., et al.. (1994). Conversion from immediate‐release to extended‐relase diltiazem in angina pectoris. Clinical Cardiology. 17(9). 484–488. 2 indexed citations
17.
Jacobson, Terry A., et al.. (1994). Fluvastatin with and without niacin for hypercholesterolemia. The American Journal of Cardiology. 74(2). 149–154. 80 indexed citations
18.
Fromell, Gregg, et al.. (1986). The Wenckebach phenomenon. Journal of Emergency Medicine. 4(2). 115–118. 4 indexed citations
19.
Fedan, Jeffrey S., et al.. (1981). Effect of Mount St. Helens ash on the response of rat trachea to smooth muscle agonists. Environmental Research. 26(2). 497–502. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Harper Breakdown of academic impact, for papers by Giulio Francesco Romiti Breakdown of academic impact, for papers by Jannik Langtved Pallisgaard Breakdown of academic impact, for papers by Albert Yuh‐Jer Shen Breakdown of academic impact, for papers by Huon Gray Breakdown of academic impact, for papers by Michel R. Le May Breakdown of academic impact, for papers by Savion Gropper Breakdown of academic impact, for papers by M. L. Simoons Breakdown of academic impact, for papers by José Marı́a Garcı́a-Acuña Breakdown of academic impact, for papers by Liang-Miin Tsai
Rankless by CCL
2026